• Alleviating Needle Phobia How does Vein Finder Technology Help Anxious Patients

    This is where Vein Visualization Technology (Vein Finders) is changing the game. Beyond just locating veins, these devices are becoming essential tools for psychological comfort and patient retention.


    1️⃣ The Science of Fear: Why “First-Stick Success” Matters

    Anxiety often stems from the fear of pain and the “unknown.” Patients are terrified of the nurse “fishing” for a vein.

    The Stat: Studies show that multiple insertion attempts significantly increase patient distress.

    The Solution: Vein finders utilize Near-Infrared (NIR) technology to project a real-time map of the vasculature on the skin. This dramatically increases the First-Stick Success Rate, assuring the patient that the procedure will be quick and accurate.



    2️⃣Visual Reassurance: Seeing is Believing
    One of the most overlooked benefits of vein finders is Visual Reassurance.
    For the Nurse: It confirms the best insertion site before the needle touches the skin.
    For the Patient: When a patient sees the glowing map of their own veins, they often feel a sense of relief. They can see that their veins are visible and accessible. This transparency builds immediate trust in the clinician’s ability.
    Pro Tip: Many pediatric nurses use the "cool green light" of the device to distract children, turning a scary procedure into an interesting visual experience.


    3️⃣ Reducing Procedure Time
    Anxious patients often require more time to calm down, disrupting the clinic's schedule. By using a vein detector:
    Vein assessment time is reduced.
    The likelihood of calling a second nurse for help is minimized.
    The overall procedure time is shortened, meaning the patient spends less time in a state of high anxiety.


    Interested in becoming a distributor? Contact us for wholesale pricing.

    Also welcome to contact us, we are ZD Medical Inc.
    Tel : +86-187 9586 9515
    Email : sales@zd-med.com
    Whatsapp/Mobile : +86-187 9586 9515


  • Early detection of diabetic retinopathy using OCT imaging

    1) Traditional Screening Methods and Their Limitations


    Traditionally, the screening and staging of DR Mainly relied on color fundus photography to observe two-dimensional surface lesions such as retinal microaneurysms, hemorrhage and exudation. However, this method has limitations:

    Strong subjectivity: Relying on the doctor’s experience.

    Inability to observe deep structures: It is impossible to quantitatively assess the early structural damage of the retina, especially the early morphology of diabetic macular edema (DME).



    2) The core role of OCT in the early detection of DR

    OCT is a non-contact and non-invasive cross-sectional imaging technique, similar to “optical biopsy”, which can provide micrometer-resolution images of each layer of the retina. Its application in early DR Is mainly reflected in the following aspects:

    1. Detect subclinical diabetic macular edema

    Key finding: OCT can detect before clinically visible retinal thickening or hard exudation (visible in traditional fundus photography) occurs in patients:

    A slight thickening of the inner layer of the retina.

    Early and local damage to the outer structures of the retina (such as the ellipsoid zone and the external membrane).

    Tiny cystoid hyporeflex cavities (early cystoid edema).

    Significance: This enables doctors to initiate or intensify treatment (such as optimizing blood sugar and blood pressure control, or considering early anti-VEGF therapy) before vision decline occurs, thereby protecting central vision.


    2. Quantify the thinning of the retinal nerve fiber layer and ganglion cell layer

    Key finding: DR Is not only a vascular disease but also a neurodegenerative disorder. OCT can precisely measure:
    Retinal nerve fiber layer (RNFL) thickness: RNFL thinning can occur in patients with early-stage DR, which is related to the course of diabetes and blood glucose control.
    Ganglion cell-inner plexiform layer (GC-IPL) thickness: This is a more sensitive indicator. Its thinning may occur earlier than microvascular lesions, suggesting early neuronal damage related to diabetes.

    Significance: It provides objective biomarkers for the early neurodegeneration of DR, which is helpful for a comprehensive assessment of the condition.


    3. Identify subtle vascular abnormalities and ischemia
    OCT angiography (OCTA)

    : This is a revolutionary extension of OCT technology. Three-dimensional retinal and choroidal vascular maps can be generated without the injection of contrast agents.
    Early detection: It can clearly show the expansion and irregular shape of the non-perfusion area (ischemic area), the avascular area of the fovea centrae in the macular region (FAZ), and the reduced density of the retinal capillary network. These changes may occur in the early stage of DR (even in the non-proliferative phase).

    Advantages: Non-invasive, rapid and repeatable, it avoids the allergic risks associated with fluorescence angiography and is highly suitable for follow-up and monitoring.


    4. Monitor the changes at the vitreoretinal interface

    Key finding: Early DR May lead to abnormal adhesion or partial detachment of the posterior vitreous cortex (PVD), which is a risk factor for future traction, vascular rupture or macular edema. OCT can clearly display these subtle interface changes.

    3) Summary of OCT Technology Advantages
    High resolution and objective quantification: Provide objective and quantifiable data (thickness, volume, density), reducing subjective errors.
    Non-invasive and fast: Highly accepted by patients, suitable for routine screening and frequent follow-up.
    Three-dimensional and hierarchical analysis: It can precisely locate the level of the lesion in the retina.
    Function Expansion (OCTA) : It has achieved non-invasive capillary-level blood flow imaging, significantly enhancing the ability to detect early ischemia and vascular abnormalities.

    4) Application Paths in Clinical Practice
    Screening stage: For all patients with type 2 diabetes and those with a longer course of type 1 diabetes, in addition to traditional fundus photography, OCT (especially macular OCT) should be included as part of baseline examination and annual screening when conditions permit.
    Diagnosis and staging: When mild non-proliferative DR (NPDR) is detected by fundus photography, OCT can assess whether there is subclinical macular edema or thinning of the nerve layer, helping to conduct more precise risk stratification.
    Treatment decision-making and follow-up: For patients who have developed DME or require panretinal photocoagulation, OCT is the gold standard tool for guiding treatment (anti-VEGF, laser) and evaluating efficacy. OCTA is used to assess the degree of ischemia.


    Interested in becoming a distributor? Contact us for wholesale pricing.

    Also welcome to contact us, we are ZD Medical Inc.
    Tel : +86-187 9586 9515
    Email : sales@zd-med.com
    Whatsapp/Mobile : +86-187 9586 9515


  • Emergency to Routine Care with Poclight POCT Cardiac Testing Solutions

     

    1.  Introduction:

     

    As winter approaches and flu season peaks, the strain on cardiovascular health intensifies. The physiological stress caused by viral infections can often mask or exacerbate underlying cardiac conditions. For healthcare providers, the ability to rapidly differentiate between respiratory symptoms and acute cardiac events is critical. This is where the Poclight C5000 Micro CLIA System redefines the standard of care.

     

    2.  The Role of Cardiac Markers:

     

    Early intervention saves lives. Our comprehensive cardiac panel provides clinicians with a full diagnostic spectrum:

    ● D-dimer: Rapidly rule out pulmonary embolism (PE), a frequent complication in severe respiratory cases.

    ● High sensitive Cardiac Troponin T (hs-cTnT) Test Kit: The high-sensitivity gold standard for diagnosing Acute Myocardial Infarction (AMI).

    ● BNP & NT-proBNP: Precision tools for diagnosing and monitoring Heart Failure (HF) symptoms.

    ● CK-MB & Myo: Reliable early markers for assessing the onset of myocardial injury.

     

    Cardiac panel

     

    3.  Why Choose Poclight C5000 Micro CLIA System?

     

    Our Stand-out features:

    1)  Small Sample Volume & Rapid Results

    Only 50 μL of serum or plasma needed, with 5-minute turnaround, ideal for fast clinical decisions.

     

    Parameter

    Sample types

    Assay duration

    Sample volume

    Measuring range

    D-dimer

    P

    5min

    50 μL

    0.25~20 mg/L

    BNP

    P

    5min

    100 μL

    15~5000 pg/mL

    NT-proBNP

    S/P

    5min

    100 μL

    15~35000 pg/mL

    CK-MB

    S/P

    5min

    50 μL

    0.3~300 ng/mL

    Myo

    S/P

    5min

    50 μL

    21~3000 ng/mL

    hs-cTnT

    S/P

    10min

    200 μL

    5~10000 ng/L

     

    2)  Freeze-dried reagents: no cold chain, 18 months shelf life, simplifying storage and transport.

    3)  High accuracy and excellent precision

     

    cardiac performance

     

    4)  Applicable with the C5000 POC CLIA Analyzer: 3-Step Operation, Maintenance-Free

     

    C5000 POC CLIA

     

    Contact us to learn about local distributors and pricing options for Poclight Cardiac solutions. 

  • How to Choose the Right Medical Cart for Hospitals

    In modern hospitals, efficiency directly affects patient care. Medical carts are no longer simple transport tools—they function as mobile nursing stations, emergency support units, and workflow assistants used throughout the day. Choosing the right medical cart helps improve staff efficiency, reduce physical strain, and support infection control standards.

     This guide outlines the key factors hospitals should consider when selecting medical carts, focusing on materials, design features, and supplier capabilities.

     

    Medical Cart Materials: Why Lightweight Aluminum Matters

    Traditionally, stainless steel has been widely used for medical carts due to its strength and durability. However, daily hospital operations require staff to push carts over long distances, making weight an important consideration—especially for carts used frequently, such as mobile medical medication cart systems in wards and pharmacies.

    Aerospace-grade aluminum alloy is increasingly preferred because it is significantly lighter while still offering excellent load-bearing capacity and impact resistance. This reduces physical strain on medical staff and improves maneuverability in busy corridors. In addition, aluminum naturally resists corrosion and rust, making cleaning and disinfection easier—an essential factor for maintaining infection control standards. Its smooth surface and modern appearance also contribute to a cleaner, more professional hospital environment.

     

    Medical Cart Design Features That Improve Daily Use

    Beyond materials, practical design details determine how well a medical cart performs in real hospital scenarios.

    High-quality wheels should move smoothly and quietly, especially in wards where minimizing noise is important for patient comfort. Reliable braking systems are equally critical, allowing carts to remain stable during procedures or urgent situations, such as when using a medical emergency cart in fast-paced clinical environments.

    Adjustable handle heights help accommodate staff of different statures, reducing fatigue during long shifts. Modular design is another key factor. Carts that allow drawers, baskets, and accessory holders to be added or removed can be adapted to the needs of different departments, improving usability and extending product lifespan.

     

    Choosing a Medical Cart Supplier: Brand, Service, and Customization

    Selecting a medical cart is not just about the product itself, but also about the supplier’s understanding of clinical workflows. Hospitals increasingly rely on solutions like a mobile clinical workstation, which combines storage, mobility, and digital support into a single platform.

    Manufacturers that focus on ergonomic design, lightweight structures, and modular configurations are better positioned to meet these evolving needs. Some suppliers, such as Likaymo, emphasize aluminum-based structures combined with customizable layouts, allowing carts to be adapted for emergency care, anesthesia, or routine nursing tasks. The ability to provide customization and long-term support ensures that carts integrate smoothly into daily operations rather than becoming fixed, one-size-fits-all tools.

     

    Matching Medical Carts to Different Hospital Departments

    Different departments often prioritize different cart features:

    Emergency departments: high mobility, stable braking systems, modular storage

    Nursing stations: ergonomic handles, quiet wheels, organized drawers

    Procedure and anesthesia rooms: easy-to-clean surfaces and customized configurations

    Choosing carts based on real usage scenarios helps maximize efficiency and safety.

    Focus on Practical Needs and Long-Term Value

     

    Selecting medical carts is a long-term investment in workflow efficiency, staff well-being, and patient safety. Rather than focusing solely on price or traditional materials, hospitals should consider lightweight construction, user-centered design, and the supplier’s ability to adapt carts to specific clinical environments.

    By choosing medical carts based on actual operational needs, hospitals can build more efficient, flexible, and sustainable care systems.If you would like to learn more, please visit our websitewww.likaymo.com

  • Why Are More Hospitals Upgrading to Smart Mobile Workstations?

    In the fast-paced healthcare environment, traditional workflows face significant challenges. Nursing staff walk an average of several kilometers per shift, with a substantial portion of their time consumed by information transfer and locating supplies. This inefficient model is driving the demand for innovative smart mobile workstation solutions.

     

    Three Major Bottlenecks of Traditional Work Models

    Information Delay Challenges
    Paper-based medical record systems lead to delayed information updates, hindering clinical collaboration and often causing critical decision-making to be obstructed by information asymmetry.

     

    Equipment Fragmentation Issues
    Monitoring devices, computer terminals, medications, and consumables require multiple carts for transport, not only occupying space but also increasing operational complexity.

     

    Separation of Staff from Technology
    Fixed workstations force healthcare providers to repeatedly leave the patient's bedside, consuming valuable treatment time with unnecessary movement.

     

    all-in-one work station

    Core Advancements of Intelligent Solutions

    Integrated Information Hub
    Modern solutions represented by the Likaymo OS-6 Smart All-in-One Station integrate medical-grade touchscreen computer systems, enabling seamless direct connection with HIS/EMR systems. Its high-definition anti-glare touchscreen supports various operational environments, ensuring that information review, order execution, and real-time documentation can be completed at the bedside.

     

    Continuous Power Security System
    The device features a built-in intelligent UPS uninterruptible power supply, providing a critical operational window during sudden power outages to ensure data security and proper device shutdown. The smart battery management system supports extended continuous operation.

    The Evolution of Smart Healthcare

    Forward-thinking hospitals are already utilizing platforms like Likaymo OS-6 to achieve:

    • IoT Integration: Automatic association of patient information through RFID technology

    • Intelligent Decision Support: Real-time alert systems based on clinical guidelines

    • Remote Collaboration: High-definition consultations and expert guidance over 5G networks

    • #
       
    • #
       
    • #
       
    • #

    The core of healthcare digital transformation lies in integrating intelligent technology into workflows.The Likaymo OS-6 Smart All-in-One Mobile Workstation truly realizes the concept of "bringing the workstation to the patient's bedside" through triple innovation in hardware integration, software connectivity, and power security. This represents not merely a tool upgrade but a fundamental advancement in healthcare service delivery models.

     

    If you would like to learn more, please visit our website: www.likaymo.com

  • Early Cancer Screening Made Efficient Poclight CEA & Multi-Tumor Marker CLIA POCT Solution

     

    1. Introduction - Why Tumor Marker Screening Matters

     

    Cancer remains a major global health challenge. While tissue biopsy and imaging are gold standards, serum tumor marker testing provides a minimally invasive way to support early detection, disease monitoring, and recurrence surveillance, especially when combined in optimized diagnostic panels.

    Among these markers, Carcinoembryonic Antigen (CEA) has been widely studied and used in clinical practice, especially for gastrointestinal malignancies.

     

    2. CEA and Multi-Tumor Marker Diagnostics

    What is CEA?

     

    Carcinoembryonic antigen (CEA) Test Kit is designed for the quantitative detection of CEA, a glycoprotein that is commonly elevated in gastrointestinal malignancies.

    ● Most clinically relevant in colorectal, gastric, and pancreatic cancers.

    ● Useful for early detection in high-risk populations and monitoring recurrence after treatment.

     

    Combining CEA Testing with Other Relevant Markers

     

    ● Single CEA measurement may miss early-stage tumors.

    ● Multi-marker panels improve sensitivity and specificity by complementing CEA with other tumor-specific markers.

     

    CEA combination test

     

    Tumor marker application

     

    Key Takeaways:

     

    Multi-marker panels improve early cancer detection beyond CEA alone.

    Suitable for high-risk screening and post-treatment monitoring.

     

    3. Poclight’s Innovative Tumor Marker Diagnostic Solutions

     

    Poclight offers a comprehensive portfolio that empowers both distributors and laboratories to expand access to high-quality cancer diagnostics anywhere, anytime.

     

    1)  Advanced Platform: C5000 Dry Chemiluminescence Immunoassay Analyzer (Micro CLIA Analyzer)

     

    C5000 POC CLIA system

     

    2)  Featured Tumor Marker Panel

     

    ✓ Complete tumor marker testing portfolio: PSA, CEA, AFP, CYFRA21-1, CA19-9, CA125

    ✓ Covers multiple major cancer types (liver, lung, prostate, gastrointestinal, ovarian)

    ✓ Fast, accurate, and suitable for hospitals, health centers, and primary care facilities

     

    Poclight tumor marker parameter

     

    ✓ Rapid detection in just 5 minutes, minimal sample volume of 50 µL, simple operation, low cost, high-quality CLIA methodology, innovative CRET patented technology, precise results, and a wide linear detection range.

    ✓ Ease of Use: Minimal training required

     

    C5000 easy operation

     

    3)  Cost & Efficiency Highlight

     

    Feature

    Traditional CLIA Assay

    Poclight C5000 CLIA

    Turnaround Time

    15-30 min

    5 min

    Complexity

    High (trained technician required)

    Low (minimal training)

    Cost/ Case

    Expensive system $$$

     

    50-100 tests/kit

     

    lower per-test reagent cost for continuous high-volume processing

    Cost-efficient $

     

    25 tests/kit

     

    ideal for small labs & POCT

     

    Key Message: Poclight POC CLIA system reduces time, sample volume, and operational complexity, making multi-marker cancer screening more accessible and cost-effective.

    More tumor marker and other assays in progress:PGⅠ|PGⅡ|HE4|CA15-3

     

    Poclight Biotech is actively seeking global partners who share our vision for accessible, high-quality diagnostics. Interested in integrating CEA and other tumor marker diagnostics into your workflow or portfolio? Contact us to learn more.

     

  • Raising the Standard Innovation and Safety in AIC's Professional Biological Sample Shipping Packaging

    In the context of the rapidly advancing global biopharmaceutical and precision medicine fields, the integrity and safe transit of biological samples are critical determinants of experimental and diagnostic success. AIC Biological Bags is establishing itself as a trusted partner for medical and research institutions through its in-depth R&D and strict quality control in the field of specialized transport packaging.

    specimen package

    Our products are not ordinary packaging; they are exclusively designed for the shipment of high-value biological samples, diagnostic reagents, and cold chain items. They strictly adhere to international and industry regulations, ensuring the safety of samples at every step, from collection point to laboratory.

     

    Specialization: Ensuring Sample Integrity and Compliance

     

    The core advantage of AIC's biological sample transport packaging lies in its deep adherence to medical regulations and high-standard safety design:

     

    Regulatory Compliance (UN 3373): Our packaging strictly complies with the requirements of the International Air Transport Association (IATA) and relevant national health regulatory bodies for the transport of Infectious Substances (e.g., UN 3373, Biological Substance, Category B), ensuring smooth and lawful global shipping.

     

    Superior Leak Protection: Utilizing multi-layer construction and specialized sealing technology, our packaging offers exceptional leak-proof protection. This is crucial for preventing the potential spread of biohazards and safeguarding personnel and public safety.

     

    Temperature Resistance and Durability: The packaging materials possess excellent temperature resistance, making them compatible with the low-temperature environments of cold chain logistics, and ensuring the packaging maintains structural stability against damage throughout complex logistics processes.

     

    Driven by Innovation: Facing the Future of Biopharmaceutical Logistics

     

    AIC continuously invests in innovation to address the challenges in biopharmaceutical logistics:

     

    Customized Solutions: We offer packaging with customizable sizes, insulating layers, and indicators to meet the transport needs of various sample types (such as blood, urine, tissue, or cells) and different temperature control requirements (such as frozen, refrigerated, or ambient).

     

    Traceability Support: The packaging design facilitates easy labeling and scanning to support logistics information traceability, which is an indispensable part of clinical trials and diagnostic procedures.

     

    AIC: Your Reliable Pharmaceutical Logistics Partner

     

    AIC Biological Sample Shipping Packaging is your professional tool for ensuring the safety of high-value biological assets. Choosing us means choosing safety, compliance, and reliability, allowing your research and medical teams to focus on core tasks without worrying about the risks of sample transport.

  • Beyond Flow Cytometry Capture the Real-Time Vitality of Regeneration with Our Breakthrough CD Factor Detection Technology

    The revolutionary Low Speed Centrifugation Concept (LSCC) has proven that the key to superior tissue regeneration lies in the selective enrichment of leukocytes and platelets. As research confirms, lower RCF protocols significantly boost the release of essential growth factors like VEGF and TGF-β1.

    However, the scientific community has long been hindered by the limitations of traditional flow cytometry. Standard methods often require complex anti-coagulation pre-treatment, which can mask the true, immediate activation state of the cells.

    Introducing Poclight's Pioneering CD Factor Detection System—a proprietary methodology designed to move beyond "static counting" and into the era of "functional insight."

    CD Marker Immunoassays

     

    Three Core Breakthroughs for Clinical Excellence

     

    1. Resilience Against Platelet Interference In many clinical scenarios, especially with patients suffering from low platelet counts, traditional detection is prone to error due to platelet aggregation and concentration fluctuations. Poclight's unique methodology is independent of platelet aggregation and concentration, finally solving the long-standing challenge of functional assessment in low-count patients. We provide a clear, accurate diagnostic window where others see only noise.

    2. Standardized, High-Speed Performance Time is critical in clinical settings. Unlike the multi-step, complex pre-processing required for flow cytometry, our standardized system requires no complex pre-treatment.

    Speed: Obtain reliable results in just 5–10 minutes.

    Dual Functionality: Simultaneously detect platelet activation states and aggregation functions, providing a comprehensive metabolic profile of the regenerative matrix in real-time.

    3. A One-Stop Solution for Life Sciences and Clinics We provide a seamless bridge between laboratory research and clinical application. By offering a one-stop solution for CD factor analysis, we are pushing the boundaries of platelet function research into a more precise, efficient, and data-driven new stage.

    True Accuracy Reflects True Activation

    Poclight's technology captures the authentic and immediate state of cellular activation. By reflecting the cells as they truly behave within the patient’s own biological environment, we provide clinicians with the most accurate basis for judgment.

    Contact us today to discover how our exclusive CD Factor Detection Kits can redefine your outcomes.

     

     

     

     

  • AI + OCT How can artificial intelligence help ophthalmologists diagnose faster and more accurately?

    The combination of artificial intelligence (AI) and optical coherence tomography (OCT) is revolutionizing the diagnostic model of ophthalmic diseases. The core of this integration lies in combining the powerful data analysis capabilities of AI with the high-resolution biological tissue structure imaging of OCT, thereby providing doctors with insights that exceed the limits of human vision. Specifically, AI has provided revolutionary assistance in the following aspects

    I. Core Support: Faster, More Accurate, and Smarter
    1.Ultra-high-speed quantitative analysis and screening
    What to do: AI algorithms can automatically complete the analysis of the entire OCT three-dimensional volume scan within seconds, accurately segment each layer of the retina structure (such as the nerve fiber layer, photoreceptor cell layer, etc.), and measure its thickness and volume.
    Traditional pain points: Manual measurement by doctors is time-consuming and labor-intensive, and it is difficult to quantify the entire retina so precisely.
    The changes brought about: It provides objective and repeatable quantitative data for glaucoma (focusing on the optic disc and nerve fiber layer) and macular diseases (focusing on the thickness changes of each layer), greatly shortening the initial assessment time.


    2. Anomaly detection and lesion identification
    What to do: The AI model, trained on a vast amount of labeled data, can automatically identify and label various lesions in OCT images like an experienced expert, such as
    Diabetic macular edema: Detection of fluid accumulation within the retina (cystoid edema).
    Age-related macular degeneration: Identification of vitreous warts, subretinal fluid, choroidal neovascularization, etc.
    Retinal vein occlusion: Macular edema and hemorrhage are found.
    Macular holes, epiretinal membranes, etc.
    The changes brought about: AI can act as the "first reader", quickly marking suspicious lesion areas, preventing the missed diagnosis of tiny lesions due to visual fatigue or lack of experience, and is particularly suitable for large-scale community screening.


    3. Disease classification and severity grading
    What to do: AI can not only detect lesions but also automatically classify and stage diseases. For instance, to determine whether AMD is dry or wet, to grade the risk of visual field defects in glaucoma, or to assess the severity of diabetic retinopathy.
    The changes brought about: It provides doctors with standardized diagnostic references to assist in making treatment decisions and priorities (for example, which patients with wet AMD need urgent anti-VEGF treatment).


    4. Predict disease progression and treatment response
    What to do: This is the most cutting-edge application of AI. By analyzing the longitudinal OCT sequence images, the AI model can learn the patterns of disease development and predict the risk of future disease deterioration. At the same time, it can also predict the possible response of patients to specific treatments, such as anti-VEGF injections.
    The changes brought about: achieving a leap from "diagnosing the present" to "predicting the future", making personalized medicine and preventive intervention possible.

    Ii. Specific Manifestations in the Clinical Workflow
    In screening scenarios: AI-OCT systems can be deployed in communities or physical examination centers. OCT scans are operated by technicians, and AI generates reports in real time, quickly screening out high-risk patients for referral to specialists, greatly improving the efficiency and coverage of screening.
    1.In the outpatient setting:
    Before the examination: The patient has completed the OCT scan.
    2. During the examination: AI real-time analysis generates a preliminary report with color annotations, quantitative data, and suspicious findings before the doctor's consultation.
    3. Doctor's Diagnosis: Doctors do not need to analyze from scratch from a vast amount of raw data. Instead, they directly review the AI's findings and, based on their own clinical experience, confirm, correct and make a final diagnosis. This is equivalent to having an "indefatigable assistant" complete all the basic measurements and initial screening work.
    4. Follow-up Comparison: AI can automatically and precisely match and compare this scan with the patient's historical scans, highlighting the areas that have changed (improved or deteriorated), making the follow-up assessment clear at a glance.

    Iii. Core Values for Ophthalmologists
    1. Liberate productivity: Free doctors from heavy repetitive labor (measurement, comparison), allowing them to focus on decision-making, doctor-patient communication, and treatment plan formulation that require high-level clinical thinking.

    2. Enhance diagnostic capabilities: As the "second pair of eyes", it provides objective and quantitative decision support, reduces diagnostic differences among individuals, and improves the consistency and accuracy of overall diagnosis.

    3. Dealing with the data deluge: Modern OCT scans generate an enormous amount of data, and AI is an indispensable tool for processing and analyzing these big data.

    4. Empowering grassroots and non-experts: Assist grassroots hospitals or general practitioners in initially identifying complex eye diseases, promote hierarchical medical treatment, and enable more patients to receive correct referral advice in a timely manner.


    Also welcome to contact us, we are ZD Medical Inc.
    Tel : +86-187 9586 9515
    Email : sales@zd-med.com
    Whatsapp/Mobile : +86-187 9586 9515

  • How to evaluate clinical effectiveness before buying a vein finder?

    I. Evaluation of Core Technology Performance
    1. Imaging quality and clarity


    Resolution and contrast: Whether the vein images generated by the device are clear and can clearly distinguish the veins from the surrounding tissues (such as fat and skin pigments).

    Penetration depth and adaptability: Whether the venous imaging effect is stable and reliable for patients of different body types (obese, thin), skin colors, ages (newborns to the elderly), and those with edema.

    Anti-interference ability: Whether the imaging effect is affected under conditions such as strong ambient light, moist skin, tattoos or scars.

    Real-time performance: Whether the imaging has no delay and can follow the movement of the probe or the pulsation of the blood vessel in real time.


    2. Technical Principles and Safety

    Imaging technology: Understand whether near-infrared light, ultrasound, or a combination of multispectral and other technologies are used. Different techniques have their own advantages and disadvantages (for example, infrared is good for superficial veins, while ultrasound is effective for deep veins).




    Ii. Clinical Effectiveness Evaluation

    This is the most crucial part and requires objective evidence to support it.
    1.Review clinical literature and evidence-based evidence
    Search for clinical research papers on this device (or similar technology) published in peer-reviewed journals.
    Focus on key indicators
    The success rate of the first puncture: After using the equipment, especially for difficult veins (such as pediatric, elderly, chemotherapy, and obese patients), the data on the improvement of the success rate of the first puncture.
    Decreased number of puncture attempts: Whether the average number of punctures has significantly declined.
    Shortened operation time: The total time required from locating the blood vessel to successful catheterization.
    Has the incidence of patient complications decreased: Has the incidence of hematoma, permeation, phlebitis and needlestick injuries decreased?

    Patient satisfaction: Whether the patient's self-reports of pain and anxiety have improved.


    2. Obtain real-world feedback

    Contact the purchased hospital: Inquire about the actual usage experience from the nursing staff and intravenous therapy specialist nurses in hospitals of the same level or higher (especially in key departments such as pediatrics, oncology, ICU, and emergency) that have already used this equipment.
    On-site demonstration and trial use: It is required that the supplier conduct a demonstration in a real clinical environment of the hospital and have senior nurses from different departments of the hospital carry out blind tests (first conduct traditional touch/visual judgment without knowing the imaging results of the equipment, and then compare the images of the equipment) to evaluate whether the information provided by the equipment is indeed superior to the traditional method.
    Observe the integration of the workflow: Whether the equipment can be easily integrated into the existing venipuncture process, and whether it will speed up the process or cause disruptions.

    Iii. Evaluation of Operability and Practicality
    1.Ergonomic design
    Device form: Is it handheld, head-mounted or stand type? Whether it is lightweight, flexible and suitable for long-term operation.
    Display method: Is the image directly projected onto the skin or displayed on an independent screen? Whether the projection/display is clear and intuitive, without the need for the operator to frequently adjust the viewing Angle.

    Disinfection and protection: Whether the probe or the parts in contact with the patient are easy to disinfect or equipped with disposable protective covers, and meet the requirements of infection control.


    2. Usability and learning curve

    Is the interface intuitive and is the parameter adjustment simple?
    How long does it take for medical staff to be trained before they can be used independently and effectively? Does the supplier provide complete training and support?

    Iv. Economic and Operational Efficiency Assessment
    1.Cost-benefit analysis
    Direct costs: Equipment purchase price, consumables (if any), maintenance fees.
    Indirect benefits/cost savings:
    Reduce the waste of consumables (needles, dressings) caused by repeated punctures.
    Reduce the additional processing costs caused by puncture failure or complications.
    Enhance the efficiency of medical staff and save time for other nursing tasks.

    The potential risk of medical disputes has been reduced.


    2. Estimation of return on investment

    Based on the proportion of patients with difficult venipuncture in our hospital and the annual puncture volume, estimate the comprehensive benefits that can be brought by improving the success rate and reducing the operation time, and calculate the approximate payback period of investment.


    Also welcome to contact us, we are ZD Medical Inc.
    Tel : +86-187 9586 9515
    Email : sales@zd-med.com
    Whatsapp/Mobile : +86-187 9586 9515